These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The treatment of spastic states with hyoscine-N-butylbromide]. HARTMANN HG Z Arztl Fortbild (Jena); 1953 Aug; 47(15):541-3. PubMed ID: 13090960 [No Abstract] [Full Text] [Related]
4. [Studies on the pharmacologic effect and clinical use of hyoscine-N-butylbromide (buscopan)]. HEINKEL K Dtsch Z Verdau Stoffwechselkr; 1951 Jul; 11(4):180-95. PubMed ID: 14872696 [No Abstract] [Full Text] [Related]
5. [Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants]. GADEKE R Kinderarztl Prax; 1955 Nov; 23(11):486-92. PubMed ID: 13279076 [No Abstract] [Full Text] [Related]
6. Oral hyoscine butylbromide for irritable bowel syndrome? Gibbons D Br Med J; 1979 Mar; 1(6165):752. PubMed ID: 435769 [No Abstract] [Full Text] [Related]
7. Edrophonium-hyoscine butylbromide mixture for reversal of neuromuscular blockade: heart rate changes in infants and children. Yamashita M; Tajima K Anaesthesia; 1988 Jul; 43(7):591-3. PubMed ID: 3414927 [TBL] [Abstract][Full Text] [Related]
11. Hyoscine butylbromide to relieve utero-tubal obstruction at hysterosalpingography. Alper MM; Garner PR; Spence JE Br J Radiol; 1985 Sep; 58(693):915. PubMed ID: 3842296 [No Abstract] [Full Text] [Related]
12. [Sonographic study of the effect of hyoscin-N-butylbromide on cholecystokinin stimulated gallbladder motility]. Wagner T; Botzler R; Ritter U Z Gastroenterol; 1984 Jun; 22(6):305-10. PubMed ID: 6464523 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of effectiveness of 4-methylumbelliferone and hyoscine-N-butylbromide in therapy following biliary tract surgery]. Fischer D; Krumme H Med Welt; 1980 Jun; 31(23):894-7. PubMed ID: 6775170 [No Abstract] [Full Text] [Related]
14. Angioneurotic oedema and urticaria induced by hyoscine butylbromide. Robinson AC; Teeling M Postgrad Med J; 1982 May; 58(679):316. PubMed ID: 7111123 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the value of hyoscine butylbromide and glucagon on aorto iliac intravenous digital subtraction. Rowland-Hill CA; Loveday EJ; Thomas ML Vasa; 1989; 18(4):301-3. PubMed ID: 2609736 [TBL] [Abstract][Full Text] [Related]
17. Edrophonium-hyoscine butylbromide mixture in neonates. Yamashita M; Tajima K Anaesthesia; 1989 Feb; 44(2):169. PubMed ID: 2929951 [No Abstract] [Full Text] [Related]
18. Echocardiographic evaluation of vagolytic effects of hyoscine butylbromide in paediatric halothane anaesthesia. Yamashita M; Horigome H Agressologie; 1989 Sep; 30(8):489-91. PubMed ID: 2610296 [TBL] [Abstract][Full Text] [Related]
19. Letter: Rebound effect of hyoscine butylbromide on postoperative bowel contractions. Fry EN; Deshpande S Br Med J; 1976 Mar; 1(6010):646-7. PubMed ID: 1252864 [No Abstract] [Full Text] [Related]
20. Oral hyoscine butylbromide does not alter the pattern of small intestinal motor activity. Thompson DG; Wingate DL Br J Pharmacol; 1981 Apr; 72(4):685-7. PubMed ID: 7284686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]